Topic
nasdaq-listing
1 stories related to this topic, newest first.
Substrate placeholder — needs reviewfinance16 days agoSourced
Reviva Pharmaceuticals Receives Nasdaq Delisting Notice
Reviva Pharmaceuticals Holdings disclosed in an 8-K filing that Nasdaq notified the company it no longer meets the minimum bid price listing requirement. The notice starts a 180-day compliance period that ends November 10 2026 and requires the stock to maintain a closing bid pric…